Contract Research Organization
VintaBio provides cell and gene therapy manufacturing services to pharmaceutical, biotechnology, academic and government organizations that are developing drugs for use in clinical trials. VintaBio has experienced staff to drive efficiency and produce high quality cGMP grade viral vectors. Current vector capabilities include, but are not limited to, adeno-associated virus (AAV) and lentiviral vectors (LVV).